sarnsrun/medquadmini huggingface dataset:
Question:
How to diagnose Skin Cancer ?

Answer:
Tests or procedures that examine the skin are used to detect (find) and diagnose nonmelanoma skin cancer and actinic keratosis. The following procedures may be used:         -  Skin exam: A doctor or nurse checks the skin for bumps or spots that look abnormal in color, size, shape, or texture.    -  Skin biopsy : All or part of the abnormal-looking growth is cut from the skin and viewed under a microscope by a pathologist to check for signs of cancer. There are four main types of skin biopsies:               -  Shave biopsy : A sterile razor blade is used to shave-off the abnormal-looking growth.      -  Punch biopsy : A special instrument called a punch or a trephine is used to remove a circle of tissue from the abnormal-looking growth.      -  Incisional biopsy : A scalpel is used to remove part of a growth.      -  Excisional biopsy : A scalpel is used to remove the entire growth.
Question:
What is the outlook for Skin Cancer ?

Answer:
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends mostly on the stage of the cancer and the type of treatment used to remove the cancer.   Treatment options depend on the following:         - The stage of the cancer (whether it has spread deeper into the skin or to other places in the body).    - The type of cancer.    - The size of the tumor and what part of the body it affects.    - The patients general health.
Question:
what research (or clinical trials) is being done for Skin Cancer ?

Answer:
New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Treatment for skin cancer may cause side effects.
                    For information about side effects caused by treatment for cancer, see our Side Effects page.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Question:
Who is at risk for Endometrial Cancer? ?

Answer:
Obesity and having metabolic syndrome may increase the risk of endometrial cancer.
                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for endometrial cancer include the following:         - Having endometrial hyperplasia.    - Being obese.    - Having metabolic syndrome, a set of conditions that occur together, including extra fat around the abdomen, high blood sugar, high blood pressure, high levels of triglycerides and low levels of high-density lipoproteins in the blood.    -  Never giving birth.    - Beginning menstruation at an early age.    - Reaching menopause at an older age.    - Having polycystic ovarian syndrome (PCOS).     -  Having a mother, sister, or daughter with uterine cancer.    - Having a certain gene change that is linked to Lynch syndrome (hereditary non-polyposis colon cancer).     - Having hyperinsulinemia (high levels of insulin in the blood).
                
                
                    Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer.
                    Endometrial cancer may develop in breast cancer patients who have been treated with tamoxifen. A patient who takes this drug and has abnormal vaginal bleeding should have a follow-up exam and a biopsy of the endometrial lining if needed. Women taking estrogen (a hormone that can affect the growth of some cancers) alone also have an increased risk of endometrial cancer. Taking estrogen combined with progesterone (another hormone) does not increase a womans risk of endometrial cancer.
Question:
What are the symptoms of Endometrial Cancer ?

Answer:
Signs and symptoms of endometrial cancer include unusual vaginal bleeding or pain in the pelvis. These and other signs and symptoms may be caused by endometrial cancer or by other conditions. Check with your doctor if you have any of the following:         - Vaginal bleeding or discharge not related to menstruation (periods).    - Vaginal bleeding after menopause.    - Difficult or painful urination.    - Pain during sexual intercourse.    - Pain in the pelvic area.
Question:
How to diagnose Endometrial Cancer ?

Answer:
Tests that examine the endometrium are used to detect (find) and diagnose endometrial cancer. Because endometrial cancer begins inside the uterus, it does not usually show up in the results of a Pap test. For this reason, a sample of endometrial tissue must be removed and checked under a microscope to look for cancer cells. One of the following procedures may be used:         -   Endometrial biopsy : The removal of tissue from the endometrium (inner lining of the uterus) by inserting a thin, flexible tube through the cervix and into the uterus. The tube is used to gently scrape a small amount of tissue from the endometrium and then remove the tissue samples. A pathologist views the tissue under a microscope to look for cancer cells.    -   Dilatation and curettage : A procedure to remove samples of tissue from the inner lining of the uterus. The cervix is dilated and a curette (spoon-shaped instrument) is inserted into the uterus to remove tissue. The tissue samples are checked under a microscope for signs of disease. This procedure is also called a D&C.    -  Hysteroscopy: A procedure to look inside the uterus for abnormal areas. A hysteroscope is inserted through the vagina and cervix into the uterus. A hysteroscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer.        Other tests and procedures used to diagnose endometrial cancer include the following:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Transvaginal ultrasound exam: A procedure used to examine the vagina, uterus, fallopian tubes, and bladder. An ultrasound transducer (probe) is inserted into the vagina and used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The doctor can identify tumors by looking at the sonogram.
Question:
What is the outlook for Endometrial Cancer ?

Answer:
Certain factors affect prognosis (chance of recovery) and treatment options.The prognosis (chance of recovery) and treatment options depend on the following:          - The stage of the cancer (whether it is in the endometrium only, involves the uterus wall, or has spread to other places in the body).    - How the cancer cells look under a microscope.     - Whether the cancer cells are affected by progesterone.         Endometrial cancer can usually be cured because it is usually diagnosed early.
Question:
what research (or clinical trials) is being done for Endometrial Cancer ?

Answer:
New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Question:
What is (are) Endometrial Cancer ?

Answer:
Key Points
                    - Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.     - In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.    -  Health history and certain medicines can affect the risk of developing endometrial cancer.
                
                
                    Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium.
                    The endometrium is the innermost lining of the uterus. The uterus is a hollow, muscular organ in a woman's pelvis. The uterus is where a fetus grows. In most nonpregnant women, the uterus is about 3 inches long.     Cancer of the endometrium is different from cancer of the muscle of the uterus, which is called uterine sarcoma. See the PDQ summary on Uterine Sarcoma Treatment for more information.   See the following PDQ summaries for more information about endometrial cancer:         -  Endometrial Cancer Treatment     -  Endometrial Cancer Prevention
                
                
                    In the United States, endometrial cancer is the most common invasive cancer of the female reproductive system.
                    Endometrial cancer is diagnosed most often in postmenopausal women at an average age of 60 years.   From 2004 to 2013, the number of new cases of endometrial cancer increased slightly in white and black women. From 2005 to 2014, the number of deaths from endometrial cancer increased slightly in white and black women. When endometrial cancer is diagnosed in black women, it is usually more advanced and less likely to be cured.
Question:
Who is at risk for Endometrial Cancer? ?

Answer:
Health history and certain medicines can affect the risk of developing endometrial cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. People who think they may be at risk should discuss this with their doctor. Risk factors for endometrial cancer include the following:         - Taking tamoxifen for treatment or prevention of breast cancer.    - Taking estrogen alone. (Taking estrogen in combination with progestin does not appear to increase the risk of endometrial cancer.)    - Being overweight.    - Eating a high-fat diet.    -  Never giving birth.    - Beginning menstruation at an early age.    - Reaching menopause at an older age.    - Having the gene for hereditary non-polyposis colon cancer (HNPCC).     - Being white.
Question:
What is (are) Mycosis Fungoides and the Szary Syndrome ?

Answer:
Key Points
                    - Mycosis fungoides and the Szary syndrome are diseases in which lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin.    - Mycosis fungoides and the Szary syndrome are types of cutaneous T-cell lymphoma.     - A sign of mycosis fungoides is a red rash on the skin.    - In the Szary syndrome, cancerous T-cells are found in the blood.    - Tests that examine the skin and blood are used to detect (find) and diagnose mycosis fungoides and the Szary syndrome.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Mycosis fungoides and the Szary syndrome are diseases in which lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin.
                    Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood stem cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. A myeloid stem cell becomes a red blood cell, white blood cell, or platelet. A lymphoid stem cell becomes a lymphoblast and then one of three types of lymphocytes (white blood cells):         -  B-cell lymphocytes that make antibodies to help fight infection.    -  T-cell lymphocytes that help B-lymphocytes make the antibodies that help fight infection.    -  Natural killer cells that attack cancer cells and viruses.         In mycosis fungoides, T-cell lymphocytes become cancerous and affect the skin. In the Szary syndrome, cancerous T-cell lymphocytes affect the skin and are in the blood.
                
                
                    Mycosis fungoides and the Szary syndrome are types of cutaneous T-cell lymphoma.
                    Mycosis fungoides and the Szary syndrome are the two most common types of cutaneous T-cell lymphoma (a type of non-Hodgkin lymphoma). For information about other types of skin cancer or non-Hodgkin lymphoma, see the following PDQ summaries:         -  Adult Non-Hodgkin Lymphoma Treatment     -  Skin Cancer Treatment     -  Melanoma Treatment     -  Kaposi Sarcoma Treatment
                
              
                
                    In the Szary syndrome, cancerous T-cells are found in the blood.
                    Also, skin all over the body is reddened, itchy, peeling, and painful. There may also be patches, plaques, or tumors on the skin. It is not known if the Szary syndrome is an advanced form of mycosis fungoides or a separate disease.
Question:
What are the symptoms of Mycosis Fungoides and the Szary Syndrome ?

Answer:
A sign of mycosis fungoides is a red rash on the skin. Mycosis fungoides may go through the following phases:         -  Premycotic phase: A scaly, red rash in areas of the body that usually are not exposed to the sun. This rash does not cause symptoms and may last for months or years. It is hard to diagnose the rash as mycosis fungoides during this phase.    -  Patch phase: Thin, reddened, eczema -like rash.    -  Plaque phase: Small raised bumps (papules) or hardened lesions on the skin, which may be reddened.     -  Tumor phase: Tumors form on the skin. These tumors may develop ulcers and the skin may get infected.        Check with your doctor if you have any of these signs.
Question:
How to diagnose Mycosis Fungoides and the Szary Syndrome ?

Answer:
Tests that examine the skin and blood are used to detect (find) and diagnose mycosis fungoides and the Szary syndrome. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps, the number and type of skin lesions, or anything else that seems unusual. Pictures of the skin and a history of the patients health habits and past illnesses and treatments will also be taken.    -   Complete blood count with differential : A procedure in which a sample of blood is drawn and checked for the following:                - The number of red blood cells and platelets.      - The number and type of white blood cells.      - The amount of hemoglobin (the protein that carries oxygen) in the red blood cells.       - The portion of the blood sample made up of red blood cells.              -   Peripheral blood smear : A procedure in which a sample of blood is viewed under a microscope to count different circulating blood cells (red blood cells, white blood cells, platelets, etc.) and see whether the cells look normal.     -  Skin biopsy : The removal of cells or tissues so they can be viewed under a microscope to check for signs of cancer. The doctor may remove a growth from the skin, which will be examined by a pathologist. More than one skin biopsy may be needed to diagnose mycosis fungoides.    -   Immunophenotyping : A process used to identify cells, based on the types of antigens or markers on the surface of the cell. This process may include special staining of the blood cells. It is used to diagnose specific types of leukemia and lymphoma by comparing the cancer cells to normal cells of the immune system.    -  T-cell receptor (TCR) gene rearrangement test: A laboratory test in which cells in a sample of tissue are checked to see if there is a certain change in the genes. This gene change can lead to too many of one kind of T-cells (white blood cells that fight infection) to be made.    -   Flow cytometry : A laboratory test that measures the number of cells in a sample of blood, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of tumor markers on the cell surface. The cells are stained with a light-sensitive dye, placed in a fluid, and passed in a stream before a laser or other type of light. The measurements are based on how the light-sensitive dye reacts to the light.
Question:
What is the outlook for Mycosis Fungoides and the Szary Syndrome ?

Answer:
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:          - The stage of the cancer.    - The type of lesion (patches, plaques, or tumors).        Mycosis fungoides and the Szary syndrome are hard to cure. Treatment is usually palliative, to relieve symptoms and improve the quality of life. Patients with early stage disease may live many years.
Question:
what research (or clinical trials) is being done for Mycosis Fungoides and the Szary Syndrome ?

Answer:
Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Question:
What is (are) Lung Cancer ?

Answer:
Key Points
                    - Lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.    - Lung cancer is the leading cause of cancer death in both men and women.
                
                
                    Lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
                    The lungs are a pair of cone-shaped breathing organs in the chest. The lungs bring oxygen into the body as you breathe in. They release carbon dioxide, a waste product of the body's cells, as you breathe out. Each lung has sections called lobes. The left lung has two lobes. The right lung is slightly larger, and has three lobes. A thin membrane called the pleura surrounds the lungs. Two tubes called bronchi lead from the trachea (windpipe) to the right and left lungs. The bronchi are sometimes also involved in lung cancer. Tiny air sacs called alveoli and small tubes called bronchioles make up the inside of the lungs.      There are two types of lung cancer: small cell lung cancer and non-small cell lung cancer.   See the following PDQ summaries for more information about lung cancer:         -  Lung Cancer Screening     -  Non-Small Cell Lung Cancer Treatment     -  Small Cell Lung Cancer Treatment
                
                
                    Lung cancer is the leading cause of cancer death in both men and women.
                    More people die from lung cancer than from any other type of cancer. Lung cancer is the second most common cancer in the United States, after skin cancer.   The number of new cases and deaths from lung cancer is highest in black men.
Question:
What is (are) Ewing Sarcoma ?

Answer:
Key Points
                    - Ewing sarcoma is a type of tumor that forms in bone or soft tissue.    - Signs and symptoms of Ewing sarcoma include swelling and pain near the tumor.     - Tests that examine the bone and soft tissue are used to diagnose and stage Ewing sarcoma.    - A biopsy is done to diagnose Ewing sarcoma.     - Certain factors affect prognosis (chance of recovery).
                
                
                    Ewing sarcoma is a type of tumor that forms in bone or soft tissue.
                    Ewing sarcoma is a type of tumor that forms from a certain kind of cell in bone or soft tissue. Ewing sarcoma may be found in the bones of the legs, arms, feet, hands, chest, pelvis, spine, or skull. Ewing sarcoma also may be found in the soft tissue of the trunk, arms, legs, head and neck, abdominal cavity, or other areas.   Ewing sarcoma is most common in adolescents and young adults.   Ewing sarcoma has also been called peripheral primitive neuroectodermal tumor, Askin tumor (Ewing sarcoma of the chest wall), extraosseous Ewing sarcoma (Ewing sarcoma in tissue other than bone), and Ewing sarcoma family of tumors.